NCT04585139View on ClinicalTrials.gov

Assessing Non-adjunctive CGM Safety at Home and in New Markets

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

October 6, 2020

Primary Completion Date

February 7, 2022

Study Completion Date

February 7, 2022

Conditions
Diabetes Mellitus
Interventions
DEVICE

Phase 1- Introduction to Dexcom G6 CGM

Examine whether non-adjunctive use of CGM improves glycemic control in adults with diabetes managed by intensive insulin therapy

Trial Locations (1)

89074

Las Vegas Endocrinology, Henderson

Sponsors
All Listed Sponsors
collaborator

Jaeb Center for Health Research

OTHER

lead

DexCom, Inc.

INDUSTRY